Elsevier

The Lancet

Volume 346, Issue 8986, 18 November 1995, Pages 1334-1335
The Lancet

Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery

https://doi.org/10.1016/S0140-6736(95)92345-4Get rights and content

Abstract

Tumour angiogenesis is a powerful prognostic indicator in breast cancer. Shedding of tumour cells into the bloodstream is essential for haematogenous metastasis. The relation between cell shedding and angiogenesis in human cancer is not known. We studied vascular density and cell shedding in 16 women undergoing breast cancer surgery. Circulating cells were found in one patient before, in six during, and none after operation. Vascular density was related to detection of circulating tumour cells during surgery (correlation coefficient for first intraoperative sampling=0·56, p=0·024, 95% Cl 0·08 to 0·83). Tumour cell shedding during surgery is related to vascular density; the relevance of this relation to the prognostic significance of vascular density in breast cancer merits further study.

References (7)

There are more references available in the full text version of this article.

Cited by (91)

  • Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials

    2018, Breast
    Citation Excerpt :

    Many theories were proposed to explain the adverse impact of a longer surgery to chemotherapy interval on breast cancer outcomes. These include the assumption that surgical intervention might lead to an accelerated growth of micrometastatic disease [16]. Moreover, it was hypothesized that there might be an increased possibility of drug resistance in micrometastases in case of delayed chemotherapy administration [17].

  • Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells

    2016, Journal of Urology
    Citation Excerpt :

    It is important that urologists are aware of current understanding on this topic to appropriately counsel operative candidates. While there is general agreement in the scientific community regarding the common occurrence of intraoperative CTC shedding with tumor manipulation,7–18 there is also accumulating evidence that early vascular control and limitation of tumor manipulation can prevent this event.11,14,19–23 However, few groups have investigated intraoperative shedding in patients with prostate cancer.

  • Oncoplastic surgery in surgical treatment of breast cancer: Is the timing of adjuvant treatment affected?

    2013, Clinical Breast Cancer
    Citation Excerpt :

    These factors also accelerate tumor progression. The surgical trauma results in angioneogenesis and an increased number of circulating tumor cells.10 The micrometastatic disease that already has been present can further progress during surgery, and it is known to be related to a poor prognosis.4,11

View all citing articles on Scopus
View full text